Debut Plus

₹1,890.2

▲ +12.21 +0.65%

16 Jul 2026

NSE Listed

IPCA Laboratories Ltd. (IPCALAB)

Volume: 2,91,486Avg Vol 1W: 2,33,666.2Avg Vol 1M: 2,99,771.3552W Range:₹1,251.6₹1,909.9
NSE BSE www.ipca.com
Key Ratios
Checked 15h ago
Market Cap₹47,646 Cr
Current Price₹1,890.2
Previous Close₹1,877.99
High / Low (52w)₹1,909.9 / ₹1,251.6
Volume2,91,486
Avg Vol (1W)2,33,666.2
Avg Vol (1M)2,99,771.35
Stock P/E141.1
Book Value₹317.85
Dividend Yield0.4%
ROE14.2%
ROA9.6%
Revenue (TTM)₹9,032 Cr
Revenue Growth16%
Profit Margin11.8%
Total Debt₹543 Cr
Shares Outstanding25 Cr
Face Value₹1
EPS (TTM)₹13.31
P/B5.91
Debt / Equity0.1
50 DMA₹1,651.03
200 DMA₹1,498.31
Day change+0.65%
Price Chart
₹1,890.2▲ 29.31% · 1Y
₹1890₹127141.3L
2025-07-16
2026-07-15

20-day avg volume: 3.0L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 13% YoY.
  • Stock trades at a high P/E of 141.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹2,093 Cr₹2,355 Cr₹2,245 Cr₹2,247 Cr₹2,309 Cr₹2,557 Cr₹2,393 Cr₹2,388 Cr
EBITDA₹314 Cr₹367 Cr₹385 Cr₹355 Cr₹349 Cr₹469 Cr₹446 Cr₹470 Cr
Net Profit₹192 Cr₹229 Cr₹248 Cr₹68 Cr₹233 Cr₹283 Cr₹326 Cr₹299 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹3,300 Cr₹3,803 Cr₹4,686 Cr₹5,483 Cr₹5,896 Cr₹6,370 Cr₹7,830 Cr₹9,032 Cr
EBITDA₹319 Cr₹567 Cr₹763 Cr₹1,398 Cr₹1,143 Cr₹791 Cr₹1,089 Cr₹1,421 Cr
Net Profit₹239 Cr₹445 Cr₹606 Cr₹1,140 Cr₹884 Cr₹471 Cr₹547 Cr₹738 Cr
EPS18.9735.2147.7345.0134.8518.5821.5729.08
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹4,117 Cr₹4,551 Cr₹5,260 Cr₹6,068 Cr₹7,639 Cr₹8,626 Cr₹11,101 Cr₹11,761 Cr
Total Liabilities₹1,429 Cr₹1,413 Cr₹1,619 Cr₹1,352 Cr₹2,070 Cr₹2,711 Cr₹3,374 Cr₹3,372 Cr
Equity₹2,689 Cr₹3,138 Cr₹3,641 Cr₹4,716 Cr₹5,569 Cr₹5,915 Cr₹7,727 Cr₹8,388 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹399 Cr₹612 Cr₹723 Cr₹1,336 Cr₹1,058 Cr₹1,029 Cr₹1,241 Cr₹1,683 Cr
Investing₹-135 Cr₹-165 Cr₹-510 Cr₹-521 Cr₹-855 Cr₹-725 Cr₹-1,292 Cr₹-869 Cr
Financing₹-130 Cr₹-183 Cr₹-137 Cr₹-306 Cr₹427 Cr₹507 Cr₹-553 Cr₹-283 Cr
Free Cash Flow₹399 Cr₹612 Cr₹723 Cr₹1,336 Cr₹1,058 Cr₹1,029 Cr₹1,241 Cr₹1,683 Cr
Shareholding
Promoter 44.72% Institutions 48.08% Public 7.2%
Efficiency & Working Capital
ROCE18.6%
Interest Coverage20.9
Dividend Payout—
Debtor Days77 d
Inventory Days105 d
Payable Days35 d
Cash Conversion Cycle146 d
Working Capital Days181 d
Shareholding Details

As of 2026-03-31

Promoter44.7%
FII10.6%
DII37.4%
Institutions48.1%
Public7.2%
Promoter Pledge0%
No. of Shareholders82,184
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters46.3%46.3%46.3%46.3%46.3%46.3%44.7%44.7%44.7%44.7%44.7%44.7%
FIIs10%9.9%10.3%10.5%10.9%10.8%11.1%10.8%10.7%10.4%10.6%10.6%
DIIs35.2%35%33.8%34.4%33.8%34.2%35.7%36.1%36.2%36.8%37.3%37.4%
Public8.5%8.8%9.6%8.8%9.1%8.6%8.5%8.5%8.4%8.1%7.3%7.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders99,88995,93082,80981,16584,75382,97590,18988,30685,58282,87077,67382,184
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Kaygee Investments Private LimitedShareholding of Promoter and Promoter Group25.5%6.47 Cr
Hdfc Mutual Fund - Hdfc Mid-cap FundPublic Shareholding9.6%2.44 Cr
Kaygee Laboratories Private LimitedShareholding of Promoter and Promoter Group6.6%1.68 Cr
Kotak Midcap FundPublic Shareholding6.3%1.59 Cr
Dsp Midcap FundPublic Shareholding5.5%1.40 Cr
Chandurkar Investments Private LimitedShareholding of Promoter and Promoter Group5.5%1.40 Cr
Sbi Life Insurance Co. LtdPublic Shareholding3.6%90,83,602
Nippon Life India Trustee Ltd- A/c Nippon India Growth Mid Cap FundPublic Shareholding2.8%70,72,393
Premchand GodhaShareholding of Promoter and Promoter Group2.3%58,14,680
Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Midcap FundPublic Shareholding1.8%46,33,704
Usha M ChandurkarShareholding of Promoter and Promoter Group1.7%43,02,000
Hdfc Life Insurance Company LimitedPublic Shareholding1.6%39,46,423
Kotak Funds - India Midcap FundPublic Shareholding1.2%30,10,000
Mfs International New Discovery FundPublic Shareholding1.1%26,81,053
Edelweiss Trusteeship Co Ltd Ac- Edelweiss Mf Ac- Edelweiss Mid Cap FundPublic Shareholding1%26,02,635
Usha Premchand GodhaShareholding of Promoter and Promoter Group1%24,18,740
Sameer M ChandurkarShareholding of Promoter and Promoter Group0.8%20,00,000
Pranay GodhaShareholding of Promoter and Promoter Group0.7%17,00,990
Prashant GodhaShareholding of Promoter and Promoter Group0.6%15,68,644
Kalpana JainShareholding of Promoter and Promoter Group0.1%2,30,000
Xbees Traders LlpShareholding of Promoter and Promoter Group0%31,000
Makers Laboratories LimitedShareholding of Promoter and Promoter Group0%960
Bhawna GodhaShareholding of Promoter and Promoter Group0%5,000
Neetu GodhaShareholding of Promoter and Promoter Group0%4,000
Nirmal JainShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Premchand Godha00%2026-03-31
Usha M Chandurkar00%2026-03-31
Usha Premchand Godha00%2026-03-31
Sameer M Chandurkar00%2026-03-31
Pranay Godha00%2026-03-31
Prashant Godha00%2026-03-31
Kalpana Jain00%2026-03-31
Bhawna Godha00%2026-03-31
Neetu Godha00%2026-03-31
Nirmal Jain00%2026-03-31
Kaygee Investments Private Limited00%2026-03-31
Kaygee Laboratories Private Limited00%2026-03-31
Board of Directors
NameDesignationYear
Premchand GodhaExecutive Chairman2025
A K JainManaging Director & CFO2025
Pranay GodhaManaging Director & Chief Executive Officer2025
Prashant GodhaExecutive Director2025
Kamal Kishore SethIndependent Non Exe. Director2025
Narendra MairpadyIndependent Non Exe. Director2025
Harish P KamathCompany Sec. & Compli. Officer2025
Swati PatankarIndependent Director2025
Vivek ShiralkarIndependent Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1582625
Corporate Actions
TypeDateValueRemark
dividend2025-08-05₹2 (200%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202537419635943501,046
202515035100019303
2025174110000284
Insider / Designated-Person Trades

16 recent disclosure(s)

MANISH KUMAR JAINDisposal · 3,000
Pawan KothariDisposal · 2,220
Mexin Medicaments Pvt. Ltd.Disposal · 14,058
Paschim Chemicals Pvt. Ltd.Disposal · 1,01,73,000
Kaygee Investments Pvt. Ltd.Acquisition · 1,01,87,058
Mrs. Usha M. ChandurkarDisposal · 40,00,000
Substantial Acquisitions (SAST)

3 disclosure(s)

Market18/12/2024 · 40,00,000
Market04/09/2024 · 51,23,142
Market02/08/2024 · 4,09,318
Company Information
Incorporated1949
ChairmanPremchand Godha
AuditorNatvarlal Vepari & Co. LLP
Investor Email[email protected] ; [email protected]
🌐 www.ipca.com ↗

📍 48 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, 400067

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Invicta Diagnostic Ltd.Investment & Prec Cast LimitedIndian Overseas BankIndian Oil Corp Ltd.IOL Chem And Pharma Ltd.Ion Exchange (India) Ltd.Indian Phosphate LimitedIndia Pesticides LimitedIntegrated Perso Ser Ltd.IRB Infra Dev Ltd.IRB InvIT FundIrb Infrastructure TrustAll “I” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search